Exam 3 Flashcards

1
Q

Why do we need a pharmaceutical carrier?

A

protect drug from the body

protect body from the drug

Adjust PK, distribution and clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Biopharmaceutic Factors in Drug products

A

Stomach (Food effects)
Small intestine and Transit time (~3h)
Colonic transit (10-20hr)
Large Intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Adv Sustained Drug Delivery Tech

A
Infusion
Oral
Topical
Inhalation
Injection
Percutaneous
Implantation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Advantages of ER/Sustained release products

A

Sustained therapeutic blood lvls of drug

Improved pt compliance

Reduction in adverse effects and improved tolerability

Reduction in HC costs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Disadvantages of ER products

A

Dose-dumping

Less flexibility in accurate dose adjustment

less possibility for high dosage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ER drug product definition

A

dosage form that allows at least a 2fold reduction in dosage frequency as compared to that drug presented as an immediate release dosage form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Delayed release drug product definition

A

Dosage form that releases a discrete portion/portions of drug at a time other than the promptly release after admin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Targeted release drug products definition

A

dosage form tat release drug at or near the intended physiological site of action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ODTs definiton

A

disintegrate rapidly in saliva after oral admin

used without water dispersed in saliva

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Enteric coated definiton

A

type of delayed release designed to release drug in small intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Prolonged-action drug product

A

formulation whose drug activity can continue for a longer time than conventional drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Sustained-release drug product

A

designed to release a drug at predetermined rate for the constant drug conc maintaining during specific period of time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ideal ER drug product

A

release drug at constant rate

independent of pH, ionic content, other contents within GI tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Amount of drug needed in sustained-release product to maintain therapeutic drug conc is dependent on both….

A

Vd and Elim 1/2 life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Five Types of Matrix Tablets

A
  1. Hydrophobic matrix (plastic)
  2. lipid matrix
  3. hydrophilic matrix
  4. biodegradable matrix
  5. mineral matrix
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can matrix be classified?

A

by porosity situation and also by usage frequency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ion exchange products

A

insoluble drug complex containing the resin and drug dissociates in the GI tract in the presence of appropriate counter ions

drug dissolves in GI tract and is rapidly absorbed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Resin needed for anionic drugs?

A

positively charged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Resin needed for cationic drugs

A

Negatively charged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Core tablet

A

Core tablet within a tablet

Inner core suavely slow-release and outer shell is rapid release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Microencapsultion

A

process of encapsulating microscopic drug particles with a special caution material, making the drug particles more desirable in terms of physical and chemical characteristics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

2 Important requirements in development of ER products are….

A

demonstration of safety and efficacy

demonstration of controlled drug release

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Evaluation of modified released products

A

Dissolution studies

In vitro - In vivo correlations

PK studies

Clinical considerations of modified release drug products

Generic substitution of modified release drug products

24
Q

Evaluation of invivo bioavailability data

A
PK profile
Steady-state plasma drug conc
Rate of drug absorption
Occupancy time
Bioequiv studies
Statistical eval
25
Maintain particle size below what for liposome?
1 um size affects RES uptake and tissue targeting
26
Drug discovery Catch-22
Solubility is KEY, many candidates are insoluble so abandoned Micelle formation might be possible solution to deliver poorly soluble drugs
27
CMC
Critical Micellation Concentration determines stability The lower the CMC, the more stable it is
28
Fluctuations
Peaks and troughs in drug absorption profile Peaks appear at time of dose, troughs appear before next dose create a saw-tooth profile
29
Accumulation
increase in magnitude of troughs and peaks w/ each dose minimizes in each successive dose
30
Steady state
occurs when drug accumulation between doses stops peaks and troughs won't change at steady state input = output
31
Average plasma conc
average plasma conc throughout therapy shape is same as plasma conc-time profile of constant IV
32
Major factors for multiple dosing therapy?
``` How much (dose) How often (frequency of drug admin) How long (duration of therapy) ```
33
Factors affecting accumulation?
Dosing interval (inversely related)(reducing interval time = increase drug accumulation) Drug half life (directly related)(if long half life = major accumulation occurs)
34
if T1/2 / t = 1 means that...
no accumulation
35
if T1/2 / t > 1 means that...
accumulation is occurring
36
if drug half life is short then......
accumulation is negligible if T1/2 / t = <1
37
If a drug has a very short half life, shorter than dosing interval then....
it will not accumulate ie Gentamicin
38
Time to reach steady state depends on.....
half life (for exam purposes)
39
Fluctuation of Oral vs IV
Oral has lower fluctuation than IV takes awhile to absorb and then slowly declines
40
Absorption of most immediate release formulations is assumed to be....
instantaneous
41
Gradual extravascular absorption produces a higer....
Min than that produced by IV bolus
42
Fluctuation with reduced absorption will be....
minimal
43
drugs administration by intermittent IV infusions
Aminoglycosides vancomycin given by 30-60 min infusions
44
in intermittent infusion, cmax is reached when...
infusion is stopped
45
in intermittent infusion, cmin is reached when.....
when the next dose given
46
In intermittent infusions, the 2 conc measured are called....
peak and troughs
47
How does AUC change in Non-linear Pharmacokinetics?
doesn't increase linearly
48
Causes of non-linearity
Absorption Distribution Renal excretion Metabolism
49
Most common form of non-linearity?
Capacity limited metabolism occurs when therapeutic conc of drug saturate partially or completely an enzyme responsible for drug elim
50
when C<<< Km
its a first order process for metabolism increase in drug conc will increase rate of metabolism
51
when C>>>>> Km then
metabolism is 0 order process, elim rate is constant
52
When C is around Km then metabolism is...
mixed order
53
2 major compartments
Central and Peripheral
54
Drug distribution form central to peripheral is....
first order | controlled by drug amount In central compartment
55
Distribution or pseudo equilibrium is when.....
conc in central compartment equals conc in peripheral
56
two important points that require special precaution of Multi-compartment kinetics for Lidocaine and Digoxin samples
Lidocaine collect sample at pre and post distribution phase Digoxin samples collected after distribution phase
57
if you ignore distribution phase you can have errors in...
AUC Cl V